The ATP1A3 gene gives nerve cells instructions for a pump that moves sodium and potassium, helping the brain reset signals after each nerve impulse. This gene plays an important role in keeping movement, balance, and alertness steady. If it does not work properly, people may have episodes of weakness or unusual movements, seizures, developmental differences, or trouble with coordination. Variants in the ATP1A3 gene are linked to conditions including alternating hemiplegia of childhood and rapid onset dystonia parkinsonism.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or guide activities in the body. Some genes provide the directions for producing proteins, which are the parts of cells that do much of the work. Others mainly regulate when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body grows and works, and they can influence how you respond to food, stress, and medicines. For a more detailed explanation of this topic, you can read more in the LearnHub.
Overview
ATP1A3Gene function
What if the gene works
The ATP1A3 gene helps nerve cells move sodium out and potassium in. This supports normal electrical signaling in the brain and helps neurons reset after they fire.
Risk
What if the gene does not work
Variants in the ATP1A3 gene can cause episodic neurologic symptoms and movement problems, including alternating hemiplegia of childhood and rapid-onset dystonia-parkinsonism. Milder or more severe variants can influence when symptoms begin and how strongly they affect daily life.
Treatment
What does that mean for your treatment
No treatment or drug choice specific to a pathogenic or loss-of-function variant in the ATP1A3 gene is currently established. Care is usually based on symptoms, and the ATP1A3 gene is being studied to support future targeted treatments.
Conditions associated with ATP1A3
Genetic variants
What if the gene does not work
Many ATP1A3 gene variants change the protein’s shape or stability, so it reaches the cell surface poorly or moves sodium and potassium less effectively. Variants range from milder changes that partly reduce activity to more disruptive changes that impair folding, delivery to the cell surface, or sodium and potassium movement. This pattern helps explain how ATP1A3 gene variants affect function and why some are linked to later onset or narrower features, while others can cause earlier, broader nervous system symptoms.
How variants are linked to conditions
Pathogenic variants in the ATP1A3 gene cause several rare ATP1A3-related neurological conditions, most notably alternating hemiplegia of childhood, rapid-onset dystonia-parkinsonism, and CAPOS syndrome. Some variants are also linked to episodes of weakness, seizures, movement problems, balance difficulties, or developmental concerns. The exact pattern can differ from one person to another, even within the same family.
A variant is not necessarily a diagnosis
Variants in genes are a usual part of human biology and are common throughout the general population. Most have no direct impact on health and simply contribute to natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For ATP1A3-related conditions, risk is mostly driven by the gene change itself rather than lifestyle. In people who already have an ATP1A3-related condition, episodes can be brought on by things like fever, emotional stress, missed sleep, heavy exercise, heat, or alcohol, so avoiding known triggers and getting early care can help limit complications.
Inheritance of ATP1A3 variants
ATP1A3-related conditions usually follow an autosomal dominant inheritance pattern. This means a person with a disease-causing variant in the ATP1A3 gene can pass it to each child with a 50% chance. ATP1A3 inheritance can also begin with a new, de novo variant, so some affected people are the first in their family to have it. When a parent carries the variant, sons and daughters are affected with the same chance because the ATP1A3 gene is on chromosome 19, not a sex chromosome.
What does my ATP1A3 result mean for my family?
For ATP1A3-related conditions, the pattern is usually dominant, so close relatives such as a parent, brother, sister, or child may also carry the same gene change. In many families, each child of someone with a disease-causing ATP1A3 variant has a 1 in 2 chance of inheriting it. Some ATP1A3 changes happen new in a child, so a parent may not have the variant.
Genetic information
Genetic testing
How you find out about variants
ATP1A3 genetic testing usually uses a blood or saliva sample to read the ATP1A3 gene and look for variants. It can help show whether symptoms may be linked to a condition caused by a pathogenic variant in the ATP1A3 gene, although some results need careful interpretation alongside symptoms and family history.
When should I consider getting a genetic test?
Consider ATP1A3 genetic testing if a child or adult has repeated episodes of weakness or paralysis, unusual body movements, balance problems, seizures, or sudden trouble with walking or speaking, especially when symptoms started early in life. Testing can also help when these problems run in the family or when doctors suspect an ATP1A3-related condition.
A genetic result is only one part of your health story
Genetic test results can offer useful insight, but how much they reveal depends on the condition and the specific type of variant. Over time, many factors help shape how the body works, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best considered along with other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Two people can take the same treatment and have different results because their bodies may absorb, break down, or respond to the drug in different ways. These inherited differences are common and can influence how well a medicine works or how sensitive someone is to side effects. Medication response also depends on other factors, including age, liver and kidney function, and other medicines being taken.
What is Pharmacogenetics?
Pharmacogenetics is an area of study focused on how differences in genes affect the way people respond to medications. It examines links between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medicines, genes can influence how strong the effect is or how the body handles the drug. This information can support treatment decisions that are more informed and more individualized. To explore this subject further, you can read more in the LearnHub.
Drugs influenced by the ATP1A3 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response, so questions about medicines, side effects, or new symptoms are best discussed with your doctor. This matters most before starting a new treatment or if problems begin after a medication change.